Login
Israel-Hamas Conflict
Airstrike
World Cup
Social Media
Military
Artificial Intelligence
Benjamin Netanyahu
Donald Trump
Infrastructure
Immigration and Customs Enforcement
Baseball
Natural Disasters
Cryptocurrency
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Elanco Receives Positive Opinion on Zenrelia (Ilunocitinib) From EU's Committee for Veterinary Medicinal Products (CVMP)

Summary by Charleston Gazette-Mail
Company expects approval and product supply in market before the end of third quarter

55 Articles

All
Left
5
Center
20
Right
4
dvm360.comdvm360.com
Center

Access to canine dermatitis therapy may soon expand to Europe

Elanco Animal Health’s ilunocitinib tablet (Zenrelia) was approved by the FDA in 2024.

Read Full Article
Investing.comInvesting.com
Center

Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com

Read Full Article
Seeking AlphaSeeking Alpha
Lean Right

Elanco gains positive EMA opinion for Zenrelia for itching in dogs

·United States
Read Full Article
Bennington BannerBennington Banner
+51 Reposted by 51 other sources
Center

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)

Company expects approval and product supply in market before the end of third quarter

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 69% of the sources are Center
69% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Thursday, June 12, 2025.
Sources are mostly out of (0)

Similar News Topics

Opinion

Opinion

European Union

European Union

Paris, France

Paris, France

News
For You
SearchBlindspotLocal